Cue Biopharma, Inc.
USD28.62
+4.55 (+18.93%)
CEO
Lucinda Warren
IPO Date
2018-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$24.97
Prev. Close
$24.07
Day Low
$24.80
Day High
$28.97
52W Low
$4.98
52W High
$41.42
Market Cap
$0.08B
Volume
0.12M
| 327,537 |
| $0.00 |
| 7 May 2026 | Lin Shao-Lee | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 655,074 | $30.42 |
| 10 Apr 2026 | Sandercock Colin | SVP, GENERAL COUNSEL | A-Award | Acquired | 200,000 | $0.29 |
| 10 Apr 2026 | Warren Lucinda | CHIEF BUSINESS OFFICER | A-Award | Acquired | 250,000 | $0.29 |
| 10 Apr 2026 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A-Award | Acquired | 100,000 | $0.29 |
| 6 Jan 2026 | Kiener Peter A | director | A-Award | Acquired | 24,400 | $0.34 |
| 6 Jan 2026 | Broadfoot Jill Marie | director | A-Award | Acquired | 24,400 | $0.34 |
| 6 Jan 2026 | Garzone Pamela | director | A-Award | Acquired | 24,400 | $0.34 |
| 6 Jan 2026 | Morich Frank | director | A-Award | Acquired | 24,400 | $0.34 |